How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?-Reference-Cited by-同舟云学术

How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?

Published:2014 Issue:1 Volume:49 Page:3
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Park Kyung Duk¹

Affiliation:

1. Pediatric ALL Working Party, Korean Society of Hematology, Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2014.49.1.3

Reference7 articles.

1. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

2. Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

3. Acute lymphoblastic leukaemia

4. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia

5. Minimal Residual Disease–Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 Study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study;Journal of Korean Medical Science;2017

2. Nanomedicine approaches in acute lymphoblastic leukemia;Journal of Controlled Release;2016-09

3. Favorable Outcome of Hematopoietic Stem Cell Transplantation Using a Targeted Once-Daily Intravenous Busulfan–Fludarabine–Etoposide Regimen in Pediatric and Infant Acute Lymphoblastic Leukemia Patients;Biology of Blood and Marrow Transplantation;2015-01

4. Identification of key genes affecting disease free survival time of pediatric acute lymphoblastic leukemia based on bioinformatic analysis;Blood Cells, Molecules, and Diseases;2015-01